Vaxcyte Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
/ 
Frequently asked questions
To buy Vaxcyte Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Vaxcyte Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Vaxcyte Inc. is PCVX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Vaxcyte Inc. has its primary listing on NASDAQ. You can trade Vaxcyte Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Vaxcyte Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Vaxcyte Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Vaxcyte Inc..